Is EQ-5D-5L sensitive enough to detect treatment-related changes in health status of prostate cancer patients? A nationwide Norwegian longitudinal study from the prostate cancer registry
Marjolein M. Iversen, J. Kirkeleit, T. M. Norekvål, K. Oterhals, Y. Gjelsvik, T. B. Johannesen, K. Breivik

TL;DR
This study finds that the EQ-5D-5L questionnaire is not sensitive enough to detect health changes in prostate cancer patients after treatment.
Contribution
The study evaluates the responsiveness of EQ-5D-5L in prostate cancer patients compared to disease-specific tools.
Findings
EQ-5D-5L showed minor changes in health status dimensions for prostate cancer patients.
Disease-specific tools like EPIC-26 detected large declines in sexual function and urine incontinence.
Low correlations suggest EQ-5D-5L is insufficient for capturing key health changes in prostate cancer patients.
Abstract
To examine the generic European Quality of Life 5-Dimensions questionnaire (EQ-5D-5L) responsiveness to change in health status of patients with invasive prostate cancer (PCa) from pre- to post-treatment and compare these results with the responsiveness of disease-specific instruments assumed to be particularly sensitive to change in a large sample of PCa patients. In this nationwide registry study (2017–2019), PCa patients in Norway (n = 620) and a matched reference group from the general population without previous cancer history (n = 1776) were invited. All participants completed the EQ-5D-5L, the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC-QLQ-C30) and the Expanded Prostate Cancer Index Composite short form (EPIC-26) pre- and post-treatment. Paired t-tests were performed with latent change scores in a structural equation model…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsProstate Cancer Diagnosis and Treatment · Cancer survivorship and care · Health Systems, Economic Evaluations, Quality of Life
